AIM2 deletion enhances blood‐brain barrier integrity in experimental ischemic stroke
CNS Neuroscience & Therapeutics2021Vol. 27(10), pp. 1224–1237
Citations Over TimeTop 10% of 2021 papers
Abstract
Our findings indicated that inhibiting AIM2 preserved the BBB integrity after ischemic stroke, at least partially by modulating STAT3 activation and that AIM2 may be a promising therapeutic target for cerebral ischemic stroke.
Related Papers
- → Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome(2010)246 cited
- → AIM2 Inflammasome Assembly and Signaling(2019)87 cited
- → Korean red ginseng extracts inhibit NLRP3 and AIM2 inflammasome activation(2014)80 cited
- → The absent in melanoma 2 (AIM2) inflammasome in microbial infection(2019)17 cited
- → Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation (IRC5P.453)(2014)